CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2013; 23(04): 304-307
DOI: 10.4103/0971-3026.125570
Chest Radiology Minisymposia

Significance of various pulmonary and extrapulmonary abnormalities on HRCT of the chest in scleroderma lung

Anoop Kumar Pandey
Department of Radiology, Fortis memorial Research Institute, Gurgaon, Haryana, Canada
,
Pearce Wilcox
Department of Medicine, Division of Pulmonary Medicine, University of British Columbia, Vancouver, British Columbia, Canada
,
Julie O′ Brien
Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada
,
Jennifer Ellis
Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada
,
Jacquie Brown
Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada
,
Jonathon Leipsic
Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada
› Author Affiliations
Financial support and sponsorship Nil.

Abstract

Patients with systemic sclerosis (SSc) are routinely investigated with high-resolution computed tomography (HRCT) chest for early detection and accurate characterization of complicating interstitial lung diseases. Though the primary aim of HRCT is to delineate the burden of pulmonary involvement and to characterize the nature of fibrosis to potentially help guide management, it provides an opportunity to evaluate extrapulmonary manifestations, particularly the dilated pulmonary artery, esophageal dilatation, and pericardial abnormalities which have their own clinical significance. The aim of this article is to discuss the significance of various pulmonary and extrapulmonary abnormalities that may be identified on HRCT chest of SSc patients.



Publication History

Article published online:
30 July 2021

© 2013. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: An international meta-analysis of individual patient data. Am J Med 2005;118:2-10.
  • 2 Varga J. Systemic sclerosis: An update. Bull NYU Hosp Jt Dis 2008;66:198-202.
  • 3 Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, et al. High resolution CT findings in scleroderma related lung diseases: Findings from scleroderma lung study. Chest 2008,134:358-67.
  • 4 Kim EA, Johkoh T, Lee KS, Ichikado K, Koh EM, Kim TS, et al. Interstitial pneumonia in progressive systemic sclerosis: Serial high-resolution CT findings with functional correlation. J Comput Assist Tomogr 2001;25:757-63.
  • 5 Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, Nicholson AG, et al. CT features of lung disease in patients with systemic sclerosis: Comparision with idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia. Radiology 2004;232:560-7.
  • 6 Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, et al. Histopathological Subsets of Fibrosing Alveolitis in patients with Systemic Sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002;165:1581-6.
  • 7 Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleishner Society: Glossary of terms for thoracic imaging. Radiology 2008;246:697-722.
  • 8 Pandey AK, Wilcox P, Mayo JR, Sin D, Moss R, Ellis J, et al. Predictors of Pulmonary Hypertension on High-resolution Computed Tomography of the Chest in Systemic Sclerosis: A Retrospective Analysis. Can Assoc Radiol J 2010;61:291-6.
  • 9 Shah RM, Jimenez S, Wechsler R. Significance of ground glass opacity on HRCT in long term follow up of patients with Systemic Sclerosis. J Thorac Imaging 2007;22:120-4.
  • 10 Leung AN, Miller RR, Muller NL. Parenchymal opacification in chronic infiltrative lung diseases: CT-pathologic correlation. Radiology 1993;188:209-14.
  • 11 Remy-Jardin M, Remy J, Wallaert B, Bataille D, Hatron PY. Pulmonary involvement in progressive systemic sclerosis: Sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology 1993;188:499-506.
  • 12 Lee JS, Im JG, Ahn JM, Kim YM, Han MC. Fibrosing alveolitis: Prognostic implication of ground-glass attenuation at high-resolution CT. Radiology 1992;184:451-4.
  • 13 Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655-66.
  • 14 Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis: A simple staging system. Am J Respir Crit Care Med 2008;177:1248-54.
  • 15 Harrison NK, Myers AR, Corrin B, Soosay G, Dewar A, Black CM, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991;144:706-13.
  • 16 Fischer A, Misumi S, Curran-Everett D, Meehan RT, Ulrich SK, Swigris JJ, et al. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary artery hypertension in systemic sclerosis related interstitial lung disease. Chest 2007;131:988-92.
  • 17 Baque-Juston MC, Wells AU, Hansell DM. Pericardial thickening or effusion in patients with pulmonary artery hypertension: A CT Study. AJR Am J Roentgenol 1999;172:361-4.
  • 18 Bhalla M, Silver RM, Sheperd JA, McLoud TC. Chest CT in patients with scleroderma: Prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy. AJR Am J Roentgenol 1993;161:269-72.
  • 19 Vonk MC, Van Die CE, Snoeren MM, Bhansing KJ, Van Riel PL, Fransen J, et al. Oesophageal dilatation on high-resolution computed tomography scan of the lungs as a sign of Scleroderma. Ann Rheum Dis 2008;67:1317-21.
  • 20 Pandey AK, Wilcox P, Mayo JR, Moss R, Ellis J, Brown J, et al. Oesophageal dilatation on high-resolution CT chest in systemic sclerosis: What does it signify? J Med Imaging Radiat Oncol 2011;55:535-641.
  • 21 Pitrez EH, Bredemeier M, Xavier RM, Capobianco KG, Restelli VG, Vieira MV, et al. Oesophageal dysmotility in systemic sclerosis: Comparison of HRCT and scintigraphy. Br J Radiol 2006;79:719-24.
  • 22 Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Chest 1998;113:1250-6.
  • 23 Zisman DA, Karlamangla AS, Ross DJ, Keane MP, Belperio JA, Saggar R, et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007;132:773-9.
  • 24 Devraj A, Wells AU, Meister MG, Corte TJ, Hansell DM. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology 2008;249:1042-9.
  • 25 Strollo D, Goldin J. Imaging lung disease in systemic sclerosis. Curr Rheumatol Rep 2010;12:156-61.